268 related articles for article (PubMed ID: 6161463)
1. Adjuvant chemotherapy is of value following retroperitoneal lymph node dissection for nonseminomatous testicular tumors.
Scardino PT
Urol Clin North Am; 1980 Oct; 7(3):735-45. PubMed ID: 6161463
[No Abstract] [Full Text] [Related]
2. Is adjuvant chemotherapy following retroperitoneal lymph node dissection for nonseminomatous testis cancer necessary?
Donohue JP; Einhorn LH; Williams SD
Urol Clin North Am; 1980 Oct; 7(3):747-56. PubMed ID: 6161464
[No Abstract] [Full Text] [Related]
3. Lymphadenectomy for testicular carcinoma.
Laplante MP; Mount BM
Can J Surg; 1982 May; 25(3):262-6. PubMed ID: 6177391
[TBL] [Abstract][Full Text] [Related]
4. Treatment of nonseminomatous testicular tumor with minimal retroperitoneal lymph node involvement.
Pontes JE
Prog Clin Biol Res; 1985; 203():579-83. PubMed ID: 2421343
[No Abstract] [Full Text] [Related]
5. Experience with PVB in non seminomatous germ-cell cancer of the testis.
Jacquillat C; Auclerc G; Auclerc MF; Verges J; Weil M
Prog Clin Biol Res; 1985; 203():451-6. PubMed ID: 2421336
[No Abstract] [Full Text] [Related]
6. Chemotherapy of disseminated germinal tumors of the testis--comparison of vinblastine and bleomycin with vincristine, bleomycin, and actinomycin D.
Spigel SC; Stephens RL; Haas CD; Jones HS; Lehane D; Moon TE; Coltman CA
Cancer Treat Rep; 1978 Jan; 62(1):129-30. PubMed ID: 75064
[No Abstract] [Full Text] [Related]
7. Evaluation and treatment of non-seminomatous testicular tumors: a practical approach.
Merrin CE
Urol Surv; 1979 Feb; 29(1):1-9. PubMed ID: 88117
[No Abstract] [Full Text] [Related]
8. High versus low-dose cisplatin combined with vinblastine and bleomycin and selective surgical resection of residual disease in patients with disseminated testicular cancer: a Southwest Oncology Group Study.
Crawford ED; Samson M; Klugo RC; Dawkins CA; Davis M
Prog Clin Biol Res; 1985; 203():363-80. PubMed ID: 2421331
[No Abstract] [Full Text] [Related]
9. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
[TBL] [Abstract][Full Text] [Related]
10. Our experience in regard to the relationship between the size of retroperitoneal lymph node metastases and the effect of chemotherapy in non seminomatous germ cell tumors.
Guazzieri S; Ferro G; Lembo A; Merlo F; Sperandio P; Pagano F
Prog Clin Biol Res; 1985; 203():457-62. PubMed ID: 2421337
[No Abstract] [Full Text] [Related]
11. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
[TBL] [Abstract][Full Text] [Related]
12. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors of the testis.
Jacqmin D
Eur Urol; 2008 Feb; 53(2):272-3. PubMed ID: 18045771
[No Abstract] [Full Text] [Related]
13. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer tumors of the testis.
Culine S
Eur Urol; 2008 Feb; 53(2):273-4. PubMed ID: 18045772
[No Abstract] [Full Text] [Related]
14. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
[TBL] [Abstract][Full Text] [Related]
15. Selected use of aggressive adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis.
Pizzocaro G
Prog Clin Biol Res; 1985; 203():585-90. PubMed ID: 2421344
[No Abstract] [Full Text] [Related]
16. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
Yoon GH; Stein JP; Skinner DG
Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of germ cell tumors at the threshold of the third millennium].
Géczi L; Biron P; Droz JP
Orv Hetil; 2001 Aug; 142(31):1673-9. PubMed ID: 11556261
[TBL] [Abstract][Full Text] [Related]
18. [Testicular tumor--retroperitoneal lymph node excision successful in patients with stage I nonseminomatous cancer with or without vascular invasion].
Brudermanns B
Aktuelle Urol; 2007 Jan; 38(1):1-2. PubMed ID: 17290323
[No Abstract] [Full Text] [Related]
19. The treatment of infantile embryonal carcinoma (Yolk-Sac Tumour) of the testis in children.
Wobbes T; Oldhoff J; Schraffordt Koops H; de Vries JA
Z Kinderchir; 1981 Aug; 33(4):349-54. PubMed ID: 6172910
[TBL] [Abstract][Full Text] [Related]
20. [Malignant testicular tumors in children and adolescents: concept of the MAHO 82 cooperative therapeutic study of the Society for Pediatric Oncology].
Haas RJ; Brämswig J; Göbel U; Harms D; Janka G; Weissbach L
Klin Padiatr; 1983; 195(3):196-200. PubMed ID: 6192280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
